Clinical Trials Browser

Phase 1 × Amyloidosis × venetoclax × Clear all

NCT03000660 2020-08-21

Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis

Phase 1 Terminated

Immunoglobulin Light-chain Amyloidosis, Amyloidosis